Abstract
Pregnant Sprague-Dawley rats were treated with 0, 150 or 200 mg/kg valproic acid by gavage (VPA) on days 7–18 of gestation. These doses produced no maternal toxicity, reproductive effects or effects on offspring growth and survival. Maternal plasma VPA peak levels averaged 99 and 134 μg/ml 1 h after the last treatment, values approximating human therapeutic levels. VPA offspring tested after weaning exhibited reduced open-field central, but not peripheral, activity and reduced hole-board horizontal, but not vertical, activity. No activity differences were found in a figure-8 test or on a preweaning activity test. The VPA offspring also showed lengthened straight channel swimming times, increased swimming maze errors, but only among the females, while producing no differences in maze times. VPA offspring exhibited reduced spontaneous alternation frequency and reduced startle responding to both auditory and tactile (air-puff) stimuli. The effects of VPA were dose dependent in some cases (straight channel swimming and water maze errors), or the effect was seen only in the high-dose group (open-field, hole-board, spontaneous alternation, startle). The conclusion was reached that prenatal VPA is behaviorally teratogenic in rats at relevant maternal blood concentrations and at non-malforming doses.
Similar content being viewed by others
References
Bantz EW (1984) Valproic acid and congenital malformations: A case report. Clin Pediatr 23:352–353
Bjerkedal T, Czeizel A, Goujard J, Kullen B, Mastroiacove P, Nevin N, Oakley G, Robert E (1982) Valproic acid and spina bifida. Lancet II:1096
Chapman JB, Cutler MG (1984) Sodium valproate: Effects on social behavior and physical development in the mouse. Psychopharmacology 83:390–396
Dalens B, Raynaud EJ, Gaulme J (1980) Teratogenicity of valproic acid. J Pediatr 97:332–333
Davis M (1984) The mammalian startle response. In: Eaton RC (ed) Neural mechanisms of startle behavior. Plenum, New York, pp 287–351
DiLiberti JH, Farndon PA, Dennis NR, Curry CJR (1984) The fetal valproate syndrome. Am J Med Genet 19:473–481
Douglas RT (1964) Cues for spontaneous alternation. J Comp Physiol Psychol 62:171–183
Elmazar MMA, Sullivan FM (1981) Effect of prenatal phenytoin administration on postnatal development of the rat: A behavioral teratology study. Teratology 24:115–124
Eluma FO, Sucheston ME, Hayes TG, Paulson RB (1984) Teratogenic effects of dosage levels and time of administration of carbamazepine, sodium valproate, and diphenylhydantoin on caraniofacial development in the CD-1 mouse fetus. J Craniofac Genet Dev Biol 4:191–210
Gomez M (1981) Possible teratogenicity of valproic acid. J Pediatr 98:508
Hanson JW, Smith DW (1975) The fetal hydantoin syndrome. J Pediatr 87:285–290
Hanson JW, Myrianthopoulos NC, Sedgwick-Harvey MA, Smith DW (1976) Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin sydrome. J Pediatr 89:662–668
Kao J, Brown NA, Schmid B, Goulding EH, Fabro S (1981) Teratogenicity of valproic acid: In vivo and in vitro investigations. Teratogen Carcinogen Mutagen 1:367–382
Lindhout D, Meinardi H (1984) Spina bifida and in-utero expsore to valproate. Lancet II:396
McGivern RF, Clancy AN, Hill MA, Nobel EP (1984) Prenatal alcohol exposure alters adult expression of sexually dimorphic behavior in the rat. Science 224:896–898
Middaugh LD, Santos CA, Zemp JW (1975) Phenobarbital during pregnancy alters oeprant behavior of offspring in C57BL/6J mice. Pharmacol Biochem Behav 3:1137–1139
Mullenix P, Tassinari MS, Keith DA (1983) Behavioral outcome after prenatal exposure to phenytoin in rats. Teratology 27:149–157
Nau H, Zierer R, Speilmann H, Neubert D, Gansau CH (1981) A new model for embryotoxicity testing: Teratogenicity and pharmacokinetics of valproic acid following constant rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci 29:2803–2814
Ong LL, Schardein JL, Petrere JA, Sakowski R, Jordan H, Humphrey RR, Fitzgerald JE, de la Iglesia FA (1983) Teratogenesis of calcium valproate in rats. Fund Appl Toxicol 3:121–126
Reiter LW, Anderson GE, Ash ME, Gray LE (1977) Locomoter activity measurements in behavioral toxicology: Effects of lead administration on residential maze behavior. In: Zenick H, Reiter LW (eds) Behavioral toxicology: An emerging discipline. USEPA, Research Triangle Park, NC, pp 6–1–6–18
Robert E, Guibaud P (1982) Maternal valproic acid and congenital neural tube defects. Lancet II:937
Vorhees CV (1983) Fetal anticonvulsant syndrome in rats: Dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione, and phenobarbital exposure on the structural and functional development of the offspring. J Pharmacol Exp Ther 227:274–287
Vorhees CV (1985) Fetal anticonvulsant syndrome in rats: Effects on postnatal behavior and brain amino acid content. Neurobehav Toxicol Teratol 7:471–482
Vorhees CV (1987a) Maze learning in rats: A comparison of performance in two water mazes in progeny prenatally exposed to different doses of phenytoin. Neurotoxicol Teratol (in press)
Vorhees CV (1987b) Teratogenicity and developmental toxicity of valproic acid in rats. Teratology (in press)
Vorhees CV, Butcher RE (1982) Behavioral teratogenicity. In: Snell K (ed) Developmental toxicology. Preager, New York, pp 249–297
Whittle BA (1975) Pre-clinical teratological studies on sodium valproate (Epilim) and other anticonvulsants. In: Legg NJ (ed) Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy. MCS Consultants, Tunbridge Wells, England, pp 106–111
Wilder BJ, Karas BJ (1982) Valproate: Relation of plasma concentration to seizure control. In: Woodbury DM, Penry JK, Pippenger CE (eds) Antiepileptic drugs, 2nd edn. Raven, New York, pp 591–599
Zackai EH, Melman WJ, Neiderer B, Hanson JW (1975) The fetal trimethadione syndrome. J Pediatr 87:280–284
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vorhees, C.V. Behavioral teratogenicity of valproic acid: selective effects on behavior after prenatal exposure to rats. Psychopharmacology 92, 173–179 (1987). https://doi.org/10.1007/BF00177911
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00177911